. Author manuscript; available in PMC: 2023 Jun 21.
Published in final edited form as: Drug Metab Rev. 2022 Aug 5;54(3):246–281. doi: 10.1080/03602532.2022.2097254
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Figure 3.
Proposed metabolism of evobrutinib to its major metabolites in healthy volunteers.